Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Soliris
Soliris
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
InterMune
Esbriet
Alexion
Soliris
Vivus
Qsymia
Regeneron
Eylea
Alexion’s $569,000 Drug Draws Data Demand From U.K. NICE
Bloomberg
Mon, 03/3/14 - 09:10 pm
Alexion
NICE
Soliris
Soliris® (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (aHUS)
Yahoo/BusinessWire
Sat, 11/9/13 - 12:29 pm
Soliris
atypical hemolytic uremic syndrome
Alexion
Data from Alexion's Soliris Study
Yahoo/Zacks
Sat, 09/14/13 - 10:41 am
Alexion
acute antibody-mediated rejection
kidney transplants
transplant
Soliris
Alexion's Soliris receives marketing approval in Japan
The Fly on the Wall
Fri, 09/13/13 - 09:09 am
Japan
Soliris
Alexion
atypical hemolytic uremic syndrome
Alexion: Is There Any Remaining Value in This Industry Leader?
Motley Fool
Thu, 08/22/13 - 10:36 am
Alexion
Soliris
3 Biotech Favorites With Noteworthy Drug Data
Motley Fool
Mon, 07/29/13 - 03:05 pm
Alexion
Biogen Idec
Soliris
Celgene
Revlimid
Tecfidera
[video] Why Roche May Want to Acquire Alexion
Bloomberg
Mon, 07/15/13 - 11:16 am
Roche
Alexion
M&A
Soliris
The Profitable Business of Developing Orphan Drugs
Motley Fool
Tue, 06/4/13 - 12:44 pm
orphan drugs
NPS Pharmaceuticals
Gattex
Soliris
Alexion
Genzyme
Renagel
Cerezyme
Fabrazyme
Sanofi
New Clinical Trial Data Show Substantial Improvement with Eculizumab (Soliris®) in Patients with STEC-HUS
Business Wire
Sun, 11/4/12 - 10:52 am
Soliris
hemolytic uremic syndrome
Alexion
How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse
Forbes
Wed, 09/5/12 - 12:51 pm
Alexion
Soliris
anemia
Rare diseases mean big profits for Alexion
CNN/Fortune
Tue, 09/4/12 - 11:47 am
Alexion
Soliris
Alexion's Soliris to Merck's Januvia, top 20 generate huge growth
Fierce Pharma
Fri, 08/10/12 - 06:31 pm
Merck
Alexion
Soliris
Januvia
Alexion Smashes Street's Estimates As Soliris Shines
Investors.com
Wed, 07/25/12 - 11:35 pm
Soliris
Alexion
earnings
The Cure for Alexion
TheStreet.com
Wed, 02/22/12 - 11:02 am
Alexion
PNH
Soliris
Alexion Pharmaceuticals: A Tricky Mix Of Biotech And Pharma
Seeking Alpha
Tue, 02/14/12 - 11:19 am
Alexion
Gilead
Amgen
Soliris
Biogen Idec
Alexion 3Q profit rises on growing Soliris sales
Yahoo/AP
Thu, 10/20/11 - 12:38 pm
Soliris
earnings
Alexion
Alexion, Celgene Resilient Vs. Volatile Market
Investors.com
Mon, 09/26/11 - 10:29 pm
Celgene
Alexion
Soliris
Revlimid
Alexion Pharma on a High
Yahoo/Zacks.com
Mon, 09/26/11 - 11:12 am
Alexion
Soliris
aHUS
atypical hemolytic uremic syndrome
Alexion's Soliris Product Tackles Rare Diseases
Seeking Alpha
Fri, 09/16/11 - 12:07 pm
Alexion
Soliris
aHUS
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »